After-Hours Movers 9/4: Hoku Scientific (HOKU) Up on Contract, Cascade (CAE) Lower on Results
More News related to ADCT
- Ave Maria University Deploys ADC's In-Building Cellular Gear
- ADC Will Report Fourth Quarter Financial Results On Tuesday, December 9, 2008 at 4:00 PM Eastern
- ADC Announces New, Compact Radio Head for Macro Gap Coverage
- Beacon Equity Issues Technical Trade Alerts on Market Movers: SIRI, ADCT, PMCS, ONNN, JASO, TIVO
- ADC-Developed Technology Foundational to Emerging 4G Networks
More News related to CAE
- CAE to hold a career day for candidates
- CAE posts second quarter results for fiscal year 2009
- CAE posts second quarter results for fiscal year 2009
- CAE receives orders for five full-flight simulators and training devices valued at C$63 million
- CAE receives orders for five full-flight simulators and training devices valued at C$63 million
More News related to HOKU
- Hoku Secures Key Materials for Polysilicon Production
- Hoku Scientific (HOKU) Subsidiary Secures Silicon Metals Supplies for Polysilicon Production
- Hoku Secures Silicon Metal Supplies for Polysilicon Production
- Hoku Scientific (HOKU) Reports a Q3 Loss, Sees FY09 Revenues on Track with Previous Guidance
- Hoku Scientific, Inc. Reports Second Quarter Fiscal Year 2009 Results
More News related to Special Reports
- Citi Initiates Coverage on US Soft Drink Makers
- William Blair Initiates Coverage on Data Networking Stocks
- Caris Starts Coverage on Ariba (ARBA), Concur (CNQR), salesforce.com (CRM), Taleo (TLEO)
- Oppenheimer Initiates Coverage on ViroPharma (VPHM)
- Oppenheimer Initiates Coverage on Cadence Pharmaceuticals (CADX) with an Outperform
StreetInsider.com After-Hours Movers:
Hoku Scientific, Inc. (NASDAQ: HOKU) 15% HIGHER; Hoku and Solargiga Sign Contract Worth Up to $455 Million
Martek Biosciences Corporation (Nasdaq: MATK) 8% HIGHER; reports Q3 EPS of $0.28, 4 cents better than the analyst estimate of $0.24. Revenues for the quarter were $88.4 million, versus the consensus of $86.47 million. Martek Biosciences sees Q4 EPS 24-27 cents versus 26 cents consensus. Martek Biosciences sees Q4 revenue $87M-$91M versus $89 million. Martek Biosciences sees FY08 EPS $1.06 to $1.09 versus $1.04. Martek Biosciences sees FY08 $349M-$353M versus $349 million.
Cascade Corporation (NYSE: CAE) 5% LOWER; reports Q2 EPS of $0.94, 9 cents better than the analyst estimate of $1.03. Revenues for the quarter were $150.1 million, versus the consensus of $156.03 million.
Smith & Wesson Holding (Nasdaq: SWHC) 5% LOWER; reports Q2 EPS of $0.05, 2 cents better than the analyst estimate of $0.03. Revenues for the quarter were $78 million, versus the consensus of $75.38 million.
ADC Telecommunications (Nasdaq: ADCT) 5% HIGHER; reports Q3 EPS of $0.27, 1 cent better than the analyst estimate of $0.26. Revenues for the quarter were $390 million, versus the consensus of $388.55 million. Sees Q4 sales below Q3, versus the consensus of $381 million and FY08 sales of $1.5-$1.52 billion, versus the consensus of $1.51 billion.
Take-Two Interactive Software (Nasdaq: TTWO) 0.5% LOWER; reports Q3 adj-EPS of $0.93, versus the analyst estimate of $0.54. Revenues for the quarter were $433.8 million, versus the consensus of $381.27 million. Sees Q4 revs of $285-$335 million, versus the consensus of $350 million and EPS of $0.01-$0.05, versus the consensus of $0.19. For the year revs are expected to be $1.5-$1.55 billion, versus $1.5 billion and EPS of $2.08-$2.12, versus the Street estimate of $1.83.
Related Categories
Special ReportsStocks Mentioned
+0.41Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
